11-54603337-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004703.1(OR4C46):c.662G>T(p.Cys221Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004703.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4C46 | NM_001004703.1 | c.662G>T | p.Cys221Phe | missense_variant | 1/1 | ENST00000328188.1 | NP_001004703.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4C46 | ENST00000328188.1 | c.662G>T | p.Cys221Phe | missense_variant | 1/1 | NM_001004703.1 | ENSP00000329056 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151980Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251076Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135696
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461604Hom.: 0 Cov.: 34 AF XY: 0.00000963 AC XY: 7AN XY: 727116
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152098Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.662G>T (p.C221F) alteration is located in exon 1 (coding exon 1) of the OR4C46 gene. This alteration results from a G to T substitution at nucleotide position 662, causing the cysteine (C) at amino acid position 221 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at